CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by aging populations, staffing shortages, and a push toward data-driven care ...
The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Irvine-based Masimo, which was acquired by Danaher, has received FDA clearance for a monitor feature to detect opioid-induced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results